1. Home
  2. CODA vs HOWL Comparison

CODA vs HOWL Comparison

Compare CODA & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coda Octopus Group Inc.

CODA

Coda Octopus Group Inc.

HOLD

Current Price

$9.26

Market Cap

98.9M

Sector

Industrials

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.63

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CODA
HOWL
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.9M
64.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CODA
HOWL
Price
$9.26
$0.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
50.7K
811.5K
Earning Date
01-28-2026
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
15.09
N/A
EPS
0.30
N/A
Revenue
$24,347,217.00
N/A
Revenue This Year
$30.82
N/A
Revenue Next Year
$20.84
N/A
P/E Ratio
$31.87
N/A
Revenue Growth
29.34
N/A
52 Week Low
$5.76
$0.56
52 Week High
$10.54
$2.38

Technical Indicators

Market Signals
Indicator
CODA
HOWL
Relative Strength Index (RSI) 57.07 29.78
Support Level $8.79 $0.56
Resistance Level $9.69 $0.74
Average True Range (ATR) 0.42 0.09
MACD 0.07 -0.03
Stochastic Oscillator 72.59 8.95

Price Performance

Historical Comparison
CODA
HOWL

About CODA Coda Octopus Group Inc.

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: